Exhibit Hall

HomeAttendeesExhibit Hall ▶ Guru Bars
Guru Bars

Use these quick-burst learning opportunities to collaborate with industry leaders on a variety of topics. Each Guru Bar will seat only 25 participants to create a dynamic, yet intimate group with lots of interaction. Every session offers a 10-minute outline of a problem statement, mitigating factors, the host’s perspective/solution, and a challenge or question posted to attendees, who discuss it for the remaining 5 to 10 minutes. Guru Bars are organized by categories of interest and run every 30 minutes from 11 a.m. to 2 p.m. Sunday through Tuesday in the Exhibit Hall.

Complete details on presentations can be found in the ATS Exhibit Guide, ATS Daily Bulletin, conference website, and conference mobile app.

Sunday, May 21

Guru Bar 1: Education/Awareness/Prevention Guru Bar 2: Diagnosis Guru Bar 3: Treatment Guru Bar 4: Adherence/Compliance

11 - 11:30 a.m.
Alpha1-antitrypsin Deficiency: The Major Known Genetic Risk Factor for COPD
Overview and interactive discussion of Alpha1-antitrypsin deficiency including epidemiology, genetics, diagnostic guidelines, and appropriate medical interventions.
Company: Grifols USA, LLC.

Noon - 12:30p.m.
Clinically Refractory Hyptension: A Case Study Approach
A case study of CRH: current epidemiology, treatments and its associated outcomes.

Speaker: Terry Dettling, BSN, JD, MPH, Medical Science Liaison, La Jolla Pharmaceutical Company

Company: La Jolla Pharmaceutical Company

11:30 a.m. - Noon
Uncovering a Genetic Cause of COPD: Alpha1-Antitrypsin Deficiency
Alpha-1 Antitrypsin Deficiency (alpha-1) is a genetic cause of COPD that is severely underdiagnosed with as many as 90% of the individuals living with the condition.  Learn more about the mechanism of the disease, how to determine which patients may be at risk, and about genetic testing used to diagnose this condition.
Company: Grifols USA, LLC.

1:30 - 2 p.m.
Lung Cancer Diagnosis: Current Challenges in Pulmonary Nodule Management
Clinicians face numerous challenges in the management of patients with pulmonary nodules and existing diagnostic tools often present more questions than answers. During this interactive, case-based Guru Bar you will hear from experts in the field regarding the need for new biomarkers and their potential future role in clinical practice.

Speakers: J. Scott Ferguson, MD, Associate Professor Pulmonary, and Critical Care Department of Medicine University of Wisconsin-Madison, Madison, WI; Nichole T. Tanner, MD, MSCR Associate Professor of Medicine, Co-Director Lung Screening Program, Division of Pulmonary, Critical Care, Allergy and Sleep Medicine Medical University of South Carolina , Charleston, SC
Company: OncoCyte Corporation
11 - 11:30 a.m.
Topic: Asthma/COPD
Company: Boehringer Ingelheim Pharmaceuticals, Inc.

Noon - 12:30 p.m.
Nasal High Flow: What Really Matters?
Join this interactive Guru Bar where we will outline the challenges associated with traditional oxygen therapy, review the findings from recent clinical studies and debate your implementation of Nasal High Flow for patients across the continuum of care.

Speaker: Chris Hutchinson, Product Manager, Fisher & Paykel Healthcare
Company: Fisher & Paykel Healthcare Ltd.
11:30 a.m. - Noon
PAMS: Patient Adherence Management System
Adjusting to PAP therapy is a behavioral change which can be challenging for OSA patients. PAMS delivers a dedicated sleep coaching service that provides a consistent approach to post – setup PAP patient
follow up.

Speaker: Tony Ross
Company: Philips Home Healthcare Solutions

Monday, May 22

Guru Bar 1: Education/Awareness/Prevention Guru Bar 2: Diagnosis Guru Bar 3: Treatment Guru Bar 4: Adherence/Compliance
11 - 11:30 a.m.
Clinically Refractory Hypotension: A Case Study Approach
A case study of CRH: current epidemiology, treatments and its associated outcomes.

Speakers: Annette Chavez, Pharm-D, BCPS, Director, Medical Affairs, La Jolla Pharmaceutical Company
Company: La Jolla Pharmaceutical Company
11:30 a.m. - Noon
Lung Cancer Diagnosis: Current Challenges in Pulmonary Nodule Management
Clinicians face numerous challenges in the management of patients with pulmonary nodules and existing diagnostic tools often present more questions than answers. During this interactive, case-based Guru Bar you will hear from experts in the field regarding the need for new biomarkers and their potential future role in clinical practice.

Speakers: J. Scott Ferguson, MD, Associate Professor Pulmonary, and Critical Care Department of Medicine University of Wisconsin-Madison, Madison, WI; Nichole T. Tanner, MD, MSCR Associate Professor of Medicine, Co-Director Lung Screening Program, Division of Pulmonary, Critical Care, Allergy and Sleep Medicine Medical University of South Carolina , Charleston, SC Company: OncoCyte Corporation
Noon - 12:30 p.m.
Nasal High Flow: What Really Matters?
Join this interactive Guru Bar where we will outline the challenges associated with traditional oxygen therapy, review the findings from recent clinical studies and debate your implementation of Nasal High Flow for patients across the continuum of care.
Speaker: Chris Hutchinson, Product Manager, Fisher & Paykel Healthcare
Company: Fisher & Paykel Healthcare

Tuesday, May 23

Guru Bar 1: Education/Awareness/Prevention Guru Bar 2: Diagnosis Guru Bar 3: Treatment Guru Bar 4: Adherence/Compliance
11 - 11:30 a.m.
Clinically Refractory Hypotension: A Case Study Approach
A case study of CRH: current epidemiology, treatments and its associated outcomes.

Speaker: Peter B. Wright, MBA, MPAS, PA-C, Medical Science Liaison, La Jolla Pharmaceutical Company
Company: La Jolla Pharmaceutical Company
11:30 a.m. - Noon
Lung Cancer Diagnosis: Current Challenges in Pulmonary Nodule Management
Clinicians face numerous challenges in the management of patients with pulmonary nodules and existing diagnostic tools often present more questions than answers. During this interactive, case-based Guru Bar you will hear from experts in the field regarding the need for new biomarkers and their potential future role in clinical practice.

Speakers: J. Scott Ferguson, MD, Associate Professor Pulmonary, and Critical Care Department of Medicine University of Wisconsin-Madison, Madison, WI; Nichole T. Tanner, MD, MSCR Associate Professor of Medicine, Co-Director Lung Screening Program, Division of Pulmonary, Critical Care, Allergy and Sleep Medicine Medical University of South Carolina , Charleston, SC Company: OncoCyte Corporation